Search

everythinglearnresearchcommunity

for

Search:↓

Chronic scarring alopecia is common in SLE patients and needs early detection and management.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

The absence of functional sebaceous glands causes hair follicle destruction and scarring alopecia.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

A woman with long-term scalp psoriasis developed rare scarring hair loss that didn't fully respond to treatments.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

Hair transplant and applying 5% minoxidil solution can effectively treat permanent hair loss, but it may change hair direction in some cases.

Scarring hair loss found in female pattern; biopsy needed for diagnosis.

Dense-packing follicular unit extraction is a safe and effective way to treat extensive scarring alopecia.

Most people with scarring and nonscarring hair loss show similar D2-40 levels, but some with scarring hair loss have higher levels.

Fat grafting before hair transplant may improve hair growth in scarring alopecia.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Low level laser therapy and acupuncture significantly improved hair growth in a patient with alopecia.

The man likely has tufted folliculitis causing painful, scarring hair loss.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Autologous follicular stem cells improved hair loss in 57% of patients.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

A rare scalp condition, cutis verticis gyrata, was found in a woman with primary scarring alopecia.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Trichoscopy is effective in diagnosing trichotillomania by showing specific hair patterns.

Certain growth factors affect hair loss in women and could be targeted for treatment.

Loss of oil glands and inflammation might contribute to the development of scarring hair loss.

Chemical relaxers may cause scarring alopecia in black women.

The woman was diagnosed with lichen planopilaris and can be treated with corticosteroids.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.